A Suspended Graphene Field-Effect Transistor for Ultra-Sensitive and Label-Free Detection of Cancer Biomarker miR-21
Zhiming Deng, Cong Zeng, Qihang Wu, Fumin Zhang, Pingping Zhuang

TL;DR
A new graphene-based sensor detects cancer biomarker miR-21 with high sensitivity and without labels, offering promise for early cancer diagnosis.
Contribution
A suspended graphene field-effect transistor (GFET) is introduced for ultra-sensitive, label-free detection of miR-21.
Findings
The GFET sensor achieved femtomolar detection limits for miR-21.
Binding events caused measurable changes in resistance and Dirac point shifts.
The suspended design improved carrier mobility and reduced electrical noise.
Abstract
The sensitive detection of microRNA-21 (miR-21), a key biomarker for various cancers, is crucial for early diagnosis, yet conventional methods often face limitations in sensitivity and operational complexity. Here, we report a label-free biosensor based on a suspended graphene field-effect transistor (GFET) for the direct electrical detection of miR-21. The suspended architecture isolates the graphene channel from substrate-induced interference, resulting in enhanced carrier mobility and reduced electrical noise. After surface functionalization with a specific probe, the GFET demonstrated a clear concentration-dependent response to target miR-21. The binding events were transduced into a monotonic increase in relative resistance (ΔR/R0) and a positive shift of the Dirac point (VDirac), achieving a detection limit in the femtomolar (fM) range. These results establish the suspended GFET…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5- —Scientific Research Foundation of Jimei University of China
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGraphene research and applications · Graphene and Nanomaterials Applications · Advanced biosensing and bioanalysis techniques
1. Introduction
The development of rapid, sensitive, and label-free methods for quantifying the oncogenic biomarker microRNA-21 (miR-21) is critical for early cancer diagnostics and therapeutic monitoring [1,2,3]. Current standards, such as quantitative Polymerase Chain Reaction (qPCR) and Enzyme-Linked Immunosorbent Assay (ELISA), rely on multi-step sample preparation and enzymatic amplification, processes that present challenges for point-of-care analysis [4,5,6]. This motivates the investigation of alternative platforms that combine high sensitivity with operational simplicity for real-time detection. This pursuit has led to the exploration of novel materials, such as perovskite derivatives for photodetection, and innovative device architectures, like bipolar junction transistors for protein sensing [7,8].
The performance of conventional substrate-supported graphene field-effect transistors (GFETs), a platform for direct electrical biosensing [9,10], is often limited by the graphene-substrate interface. This interface can introduce charge impurities and scattering sites that decrease carrier mobility and increase electrical noise, constraining detection sensitivity for low-abundance targets like miRNAs [11,12].
A suspended graphene architecture offers a strategy to mitigate this limitation by physically decoupling the graphene channel from the substrate. This configuration minimizes substrate-induced scattering and preserves the material’s intrinsic electronic properties, offering the potential for lower noise and enhanced signal transduction [13,14]. The fabrication of stable suspended structures for liquid-phase sensing remains technically demanding [15,16]. Their successful integration, however, is expected to enhance biosensor performance.
In this work, we report a suspended GFET platform for the sensitive, label-free detection of miR-21, as shown in Figure 1. GFET devices were fabricated by transferring a graphene membrane over pre-etched micro-cavities. A distinctive feature of our design is the exposure of both surfaces of the graphene channel to the electrolyte, which enables dual-sided functionalization. The surface is modified with Peptide Morpholino Oligomer (PMO) probes for specific capture of miR-21. This architecture enhances signal modulation and lowers the limit of detection, offering a technological path for advancing early cancer diagnostics.
2. Materials and Methods
2.1. Fabrication of Suspended GFET
Monolayer graphene was synthesized via chemical vapor deposition (CVD) on copper foils. The foils were pre-cleaned by sequential immersion in 0.1 M ammonium persulfate, deionized (DI) water, and ethanol, followed by nitrogen drying. To minimize contamination, the foils were folded into enclosed pockets before being loaded into a quartz tube furnace. Growth was initiated at 1050 °C by introducing CH_4_ (30 sccm) and H_2_ (50 sccm) into an Ar flow (200 sccm). After 30–40 min, the furnace was rapidly cooled under the same gas mixture. Concurrently, microcavities were etched into silicon wafers using standard photolithography and inductively coupled plasma (ICP) etching with a C_4_F_8_/SF_6_ gas mixture. Following resist stripping, a 50 nm gold film was deposited via electron-beam evaporation or sputtering (2 × 10^−4^ Pa) and patterned into source-drain electrodes using a lift-off process in N-methyl-2-pyrrolidone (NMP). Finally, the CVD-grown graphene was transferred onto the patterned substrates using a PMMA-assisted wet-transfer method, positioning the graphene layer to bridge the microcavities. The PMMA support layer was removed with acetone and ethanol. The completed devices were annealed at 150–180 °C in an Ar/H_2_ environment to remove transfer residues.
2.2. Surface Functionalization and miR-21 Detection
The overall procedure for surface functionalization and miR-21 detection is schematically illustrated in Figure 2. The graphene surface was first functionalized by incubating devices in a 7.8 mM solution of 1-pyrenebutyric acid N-hydroxysuccinimide ester (PBASE) in anhydrous dimethylformamide (DMF) for 1 h at room temperature. After rinsing with DMF, isopropanol (IPA), and ultrapure water, the PBASE-modified devices were immediately incubated with a 1–2 µM solution of amine-terminated DNA probes (sequence detailed in Table 1) in PBS (pH 7.8) for 40 min in the dark to facilitate covalent attachment [17]. The probe sequence, complementary to miR-21, included a 5′-terminal FAM label for fluorescence verification. Unbound probes were removed by rinsing with PBS and ultrapure water. Synthetic miR-21 stock solutions (10 µM in RNase-free water) were stored at −80 °C. For hybridization experiments, working solutions (10 fM to 100 nM) were freshly prepared in a buffer (1× SSC or 1× PBS, pH 7.4) containing 0.01–0.05% Tween-20 and 1 U/mL RNase inhibitor. Detection was performed by incubating the functionalized GFETs with the miR-21 solutions, followed by a buffer rinse before electrical measurement.
2.3. Characterization and Electrical Measurements
Device morphology and graphene integrity were examined using field-emission scanning electron microscopy (FE-SEM). The successful immobilization and spatial distribution of the FAM-labeled probes were confirmed with laser confocal microscopy. All electrical measurements were performed using a Keithley 4200A-SCS semiconductor parameter analyzer. Transfer characteristics (I_DS_ vs. V_G_) were recorded by sweeping V_G_ from −2 V to +2 V (0.05 V step) at a fixed V_DS_ of 50 mV. These sweeps were conducted after each fabrication and functionalization step to monitor the Dirac point and device stability. For real-time sensing, the device resistance was monitored at a fixed V_DS_ = 100 mV and V_G_ = 50 mV. miR-21 solutions of increasing concentrations (5 fM, 50 fM, 500 fM, 5 pM, and 50 pM) were sequentially introduced to the sensor surface. After each addition, the system was allowed to stabilize for 5 min while continuously recording the current. This duration was empirically determined to be sufficient for the signal to reach a stable plateau, which we defined as a signal drift of less than 0.5% over a 60-s interval. The sensor response was quantified as the relative resistance change (ΔR/R_0_), calculated from the real-time current data.
3. Results and Discussion
3.1. Device Fabrication and Characterization
Microscopic analyses confirmed the structural integrity of the fabricated device. The ICP-etched microcavities exhibited uniform depth and well-defined edges (Figure 3a,b), over which gold electrodes were precisely aligned (Figure 3c). Raman spectroscopy was used to evaluate the quality of the transferred graphene channel (Figure 3d). Compared to the substrate-supported area, the suspended graphene exhibited downshifts in the G (~4 cm^−1^) and 2D (~8 cm^−1^) bands, a higher I_2D_/I_G_ ratio, and narrower peak widths. These spectral features indicate strain relaxation and reduced substrate-induced doping, confirming the high crystalline quality of the suspended channel [18]. Successful DNA probe immobilization was verified using fluorescence microscopy. The suspended graphene channel displayed significantly higher fluorescence intensity from FAM-labeled probes than the non-suspended regions (Figure 3e). This result suggests enhanced molecular accessibility to the graphene surface. Figure 3f presents the fully packaged device, configured with an electrolyte reservoir for liquid-gate measurements. These characterizations validate the successful fabrication of a high-quality suspended GFET, establishing a robust platform for high-sensitivity biosensing [19,20].
3.2. Sensing Mechanism and Performance Characterization
The device’s response to surface functionalization and target binding was investigated using both spectroscopic and electrical methods to elucidate the sensing mechanism.
Raman spectroscopy was used to track the stepwise functionalization of suspended and supported graphene devices (Figure 4a,b). In their pristine state, the suspended graphene showed a downshifted G peak (at ~1579 cm^−1^) and a higher I_2D_/I_G_ ratio compared to the supported device (~1585 cm^−1^), indicating reduced initial strain and doping. Subsequent functionalization with PBASE and probe DNA induced a G peak upshift in both devices, consistent with p-type doping. Notably, the total upshift of the G peak for the suspended device was approximately twice as large (~16 cm^−1^) as that for the supported one (~8 cm^−1^). Throughout the process, the D peak intensity (~1350 cm^−1^) remained low, confirming the modification was non-destructive. This significantly larger spectral shift, resulting from the absence of substrate screening, directly demonstrates the superior sensitivity of suspended graphene to surface charge modulation.
The electrical response to functionalization was tracked by measuring the transfer curves and the corresponding Dirac point voltage (V_Dirac_) [21]. The pristine suspended device showed a V_Dirac_ near 0 V, whereas the supported device exhibited a slight initial p-doping (Figure 4c). Each subsequent functionalization step induced a stepwise positive shift in V_Dirac_ for both devices, consistent with the expected charge transfer from the attached molecules. Crucially, the magnitude of the Dirac point shift (ΔV_Dirac_) was consistently larger for the suspended device throughout the process (Figure 4d), confirming that its architecture more effectively transduces surface charge variations into electrical signals [22,23].
3.3. Quantitative Performance and Specificity
To provide quantitative analyses, we characterized the dose–response for both device types using five independent devices (Figure 5a). The target miR-21 concentration ranged from 5 fM to 50 pM. The sensor response, quantified by the relative resistance change (ΔR/R_0_ = (R − R_0_)/R_0_), was measured to construct calibration curves (Figure 5b), which showed high linearity (R^2^ > 0.996). Linear calibration curves yielded y = 0.0072 lg(x) + 0.0015 for suspended devices and y = 0.0037 lg(x) + 0.0013 for conventional devices. The sensitivity (slope) of the suspended GFET was nearly double that of the conventional device. Blank measurements in PBS yielded σ_blank_ = 5.2 × 10^−6^ (suspended) and 9.3 × 10^−5^ (conventional). Furthermore, based on the 3σ/slope method, the limit of detection (LOD) was determined to be 7 fM for the suspended device, a tenfold improvement over the 76 fM LOD of the conventional one. This enhanced performance is attributed to the suspended architecture providing both higher transduction efficiency and lower background noise. The relative standard deviation (RSD) at each concentration point was calculated to be no more than 3%, confirming the good device-to-device reproducibility achieved through our standardized fabrication and functionalization protocol.
To evaluate the sequence specificity of the biosensor, we tested its response against the target miR-21, a single-base mismatch sequence (miR-21-1MM), and a double-base mismatch sequence (miR-21-2MM). As shown in Figure 5c, the electrical response was highest for the complementary miR-21 and decreased progressively for miR-21-1MM and miR-21-2MM, respectively. This suggests the sensor’s ability to discriminate single-nucleotide variations. Moreover, the suspended graphene architecture enhances this sequence discrimination. This effect could be attributed to improved electrostatic coupling for specific hybridization, combined with the suppression of non-specific binding in the absence of a substrate. The suspended structure thus improves specificity by increasing the target signal while minimizing the response from mismatched sequences.
These spectroscopic and electrical characterizations consistently demonstrate the enhanced sensitivity of the suspended GFET architecture. By decoupling the graphene channel from the substrate, its response to surface binding events—from linker immobilization to target hybridization—is significantly amplified. This establishes the suspended platform as a more effective transducer for high-sensitivity, label-free biosensing [24,25].
4. Conclusions
In this study, we developed a suspended graphene field-effect transistor (GFET) for the label-free electrical detection of miR-21. The suspended architecture is designed to minimize substrate-induced scattering, which results in improved carrier mobility and lower electrical noise when compared to supported devices. Raman spectroscopy analysis confirmed that the graphene maintained its structural integrity following surface functionalization. The device’s performance as a biosensor was systematically evaluated. Concentration-dependent measurements for miR-21 showed a monotonic increase in relative resistance (ΔR/R_0_) and a corresponding positive shift in the Dirac point (V_Dirac_) as target concentration increased, demonstrating a detection limit in the femtomolar range. These results establish that the suspended GFET platform effectively transduces molecular binding events into measurable electrical signals. This work demonstrates that a suspended GFET, combined with a stable surface functionalization strategy, can serve as a sensitive platform for nucleic acid detection. The ability to quantify low-abundance miRNA biomarkers suggests its potential for applications in biomedical research and diagnostics. Furthermore, while the fabrication process utilizes scalable microfabrication techniques, achieving high-yield, large-scale manufacturing will require optimization of the large-area graphene transfer process. Addressing these aspects will be essential for translating this promising technology into practical point-of-care diagnostic tools.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Bartel D.P. Micro RN As: Genomics, biogenesis, mechanism, and function Cell 200416628129710.1016/S 0092-8674(04)00045-514744438 · doi ↗ · pubmed ↗
- 2Volinia S. Calin G.A. Liu C.G. Ambs S. Cimmino A. Petrocca F. Visone R. Iorio M. Roldo C. Ferracin M. A micro RNA expression signature of human solid tumors defines cancer gene targets Proc. Natl. Acad. Sci. USA 20061032257226110.1073/pnas.051056510316461460 PMC 1413718 · doi ↗ · pubmed ↗
- 3Chan J.A. Krichevsky A.M. Kosik K.S. Micro RNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells Cancer Res.2005656029603310.1158/0008-5472.CAN-05-013716024602 · doi ↗ · pubmed ↗
- 4Chen C. Ridzon D.A. Broomer A.J. Zhou Z. Lee D.H. Nguyen J.T. Barbisin M. Xu N.L. Mahuvakar V.R. Andersen M.R. Real-time quantification of micro RN As by stem-loop RT-PCR Nucleic Acids Res.200533 e 17910.1093/nar/gni 17816314309 PMC 1292995 · doi ↗ · pubmed ↗
- 5Kosaka N. Iguchi H. Ochiya T. Circulating micro RNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis Cancer Sci.20101012087209210.1111/j.1349-7006.2010.01650.x 20624164 PMC 11159200 · doi ↗ · pubmed ↗
- 6Allegra A. Alonci A. Campo S. Penna G. Petrungaro A. Gerace D. Musolino C. Circulating micro RN As: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)Int. J. Oncol.2012411897191210.3892/ijo.2012.164723026890 · doi ↗ · pubmed ↗
- 7Panchanan S. Dastgeer G. Dutta S. Hu M. Lee S.-U. Im J. Seok S.I. Cerium-based halide perovskite derivatives: A promising alternative for lead-free narrowband UV photodetection Matter 202473949396910.1016/j.matt.2024.07.010 · doi ↗
- 8Dastgeer G. Shahzad Z.M. Chae H. Kim Y.H. Ko B.M. Eom J. Bipolar Junction Transistor Exhibiting Excellent Output Characteristics with a Prompt Response against the Selective Protein Adv. Funct. Mater.202232220478110.1002/adfm.202204781 · doi ↗
